Immune Support

Vilon

Vilon (Lys-Glu)

The shortest Khavinson peptide: a two-amino-acid immune activator

Vilon is a synthetic dipeptide (Lys-Glu) from the Khavinson bioregulator program that modulates immune function. It is one of the shortest bioactive peptides in clinical use anywhere.

Vil
💉

Admin routes

Subcutaneous, Oral

🔬

Popularity

Niche

Side effects

Generally mild

🏪

AU vendors

0 rated

Key benefits

1Immunomodulatory effects in Russian clinical studies
2Extremely simple structure with low production cost
3Part of the established Khavinson bioregulator system

📈What to expect

1
Day 5-10

Possible improvement in immune markers (Russian data)

Based on community reports and published research. Individual results vary significantly.

💊Dosing protocols

Immune modulation (Russian protocol)

Dose

10 mcg

Frequency

Once daily

Duration

5-10 day courses

Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.

Research status|Used in Russian clinical practice; limited Western peer review

Overview

Vilon is a dipeptide consisting of just lysine and glutamic acid, developed at the Saint Petersburg Institute of Bioregulation. Like thymogen (Glu-Trp), it challenges the assumption that peptides need to be longer to have biological activity. In Khavinson's published work, vilon demonstrated immunomodulatory effects including T-cell activation and normalisation of cytokine profiles. It has been used in Russian clinical practice for immunodeficiency states. The challenge for Western acceptance is replicating these findings in controlled trials.

⚙️How it works

Khavinson proposes that Lys-Glu interacts directly with DNA in lymphoid cells, modulating gene expression related to immune function. Specific effects reported include activation of T-cell proliferation, normalisation of interleukin profiles, and enhancement of natural killer cell activity. The DNA-interaction mechanism for such a short peptide remains debated.

Side effects

Generally well-tolerated
mildRare

📅Research history

2000s

Vilon studied as part of the Khavinson bioregulator program

References

  1. [1]Khavinson VK, Morozov VG. 'Peptides of pineal gland and thymus prolong human life.' Neuroendocrinology Letters, 2003.

Frequently asked questions

Related peptides

Community experiences

Share your experience with Vilon. Effects, side effects, protocol details - help others make informed decisions.

Write a review

Rating:

No community reviews yet. Be the first to share your experience with Vilon.

Need to calculate your dose?

Use our free reconstitution calculator to work out syringe units for Vilon.

Open Calculator

Found this useful?

Share this guide

Disclaimer: This guide is for educational and informational purposes only. It is not medical advice. The dosing protocols listed are sourced from published research and community reports and do not constitute a recommendation. Always consult a qualified healthcare professional before using any peptide. Australian regulations classify many peptides as Schedule 4 (prescription-only) substances. Check current TGA guidelines before purchasing.